Dr. Delmore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10600 Quivira Rd. Suite 110
Sarah Cannon Cancer Institute at Overland Park Regional Medical Center
Overland Park, KS 66215Phone+1 913-541-5550Fax+1 913-541-5028
Summary
- I am a Board Certified Gynecologic Oncologist. I currently work at the Sarah Cannon Cancer Institute at Overland Park Regional Medical Center in Kansas City after 35 years in the Department of Obstetrics and Gynecology, UKSM-W. I retired as Emeritus Professor last year. I was not very good at retirement, and accepted a position at OPRMC on a part-time basis.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 1983 - 1985
- University of Kansas (Wichita)Residency, Obstetrics and Gynecology, 1980 - 1983
- University of Kansas (Wichita)Residency, Obstetrics and Gynecology, 1979 - 1979
- Baylor College of MedicineClass of 1978
Certifications & Licensure
- KS State Medical License 1980 - 2025
- MO State Medical License 2020 - 2025
- TX State Medical License 1979 - 2025
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 74 citationsPhase III trial of paclitaxel at two dose levels, the higher dose accompanied by filgrastim at two dose levels in platinum-pretreated epithelial ovarian cancer: an int...George A. Omura, Mark F. Brady, Katherine Y. Look, Hervy E. Averette, James E. Delmore
Journal of Clinical Oncology. 2003-08-01 - 99 citationsPrognostic factors in adult granulosa cell tumor of the ovaryBrigitte E. Miller, Beth A. Barron, Jim Y. Wan, James E. Delmore, Elvio G. Silva
Cancer. 1997-05-15 - 46 citationsAN UPDATE OF A PHASE II STUDY OF PACLITAXEL IN ADVANCED OR RECURRENT SQUAMOUS CELL CANCER OF THE CERVIXAndrzej P. Kudelka, Rodger J. Winn, Edwards Cl, G. Downey, Harvey Greenberg
Anti-Cancer Drugs. 1997-08-01
Professional Memberships
- Member
- Member
- Society of Gynecologic OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: